Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Investing Activities (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Cash from Investing Activities for 14 consecutive years, with $2192.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Cash from Investing Activities rose 144.67% year-over-year to $2192.0, compared with a TTM value of -$7099.0 through Dec 2024, up 97.24%, and an annual FY2024 reading of -$250867.0, up 73.4% over the prior year.
  • Cash from Investing Activities was $2192.0 for Q1 2025 at Aethlon Medical, up from -$2192.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2192.0 in Q1 2025 and bottomed at -$739165.0 in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$103228.0, with a median of -$38374.0 recorded in 2021.
  • The sharpest move saw Cash from Investing Activities plummeted 3944.91% in 2022, then skyrocketed 144.67% in 2025.
  • Year by year, Cash from Investing Activities stood at -$57934.0 in 2021, then tumbled by 161.48% to -$151486.0 in 2022, then skyrocketed by 94.19% to -$8807.0 in 2023, then soared by 75.11% to -$2192.0 in 2024, then skyrocketed by 200.0% to $2192.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for AEMD at $2192.0 in Q1 2025, -$2192.0 in Q4 2024, and -$4907.0 in Q1 2024.